Harmony Biosciences Holdings, Inc. (HRMY) › Capital ExpendituresHarmony Biosciences Holdings, Inc. (HRMY) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2019: $149.0K2020: $2.0K2021: $298.0K2022: $172.0K2023: $312.0K2024: $1.15M2025: $310.0K$310.0K2019Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$310.0K-73.1%2024$1.15M+269.6%2023$312.0K+81.4%2022$172.0K-42.3%2021$298.0K+14800.0%2020$2.0K-98.7%2019$149.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share